Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC1921757874;57875;57876 chr2:178595705;178595704;178595703chr2:179460432;179460431;179460430
N2AB1757652951;52952;52953 chr2:178595705;178595704;178595703chr2:179460432;179460431;179460430
N2A1664950170;50171;50172 chr2:178595705;178595704;178595703chr2:179460432;179460431;179460430
N2B1015230679;30680;30681 chr2:178595705;178595704;178595703chr2:179460432;179460431;179460430
Novex-11027731054;31055;31056 chr2:178595705;178595704;178595703chr2:179460432;179460431;179460430
Novex-21034431255;31256;31257 chr2:178595705;178595704;178595703chr2:179460432;179460431;179460430
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: T
  • RefSeq wild type transcript codon: ACC
  • RefSeq wild type template codon: TGG
  • Domain: Fn3-27
  • Domain position: 35
  • Structural Position: 36
  • Q(SASA): 0.3462
  • Predicted PPI site: I

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
T/A None None 0.999 N 0.565 0.456 0.298403945805 gnomAD-4.0.0 1.37294E-06 None None None None I None 0 0 None 0 0 None 0 0 0 2.3546E-05 0
T/I None None 1.0 N 0.86 0.41 0.485562757867 gnomAD-4.0.0 1.60349E-06 None None None None I None 0 0 None 0 0 None 0 0 2.8752E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
T/A 0.1928 likely_benign 0.1983 benign -0.72 Destabilizing 0.999 D 0.565 neutral N 0.487172543 None None I
T/C 0.5884 likely_pathogenic 0.5914 pathogenic -0.447 Destabilizing 1.0 D 0.765 deleterious None None None None I
T/D 0.8016 likely_pathogenic 0.8011 pathogenic -0.446 Destabilizing 1.0 D 0.863 deleterious None None None None I
T/E 0.667 likely_pathogenic 0.6819 pathogenic -0.493 Destabilizing 1.0 D 0.864 deleterious None None None None I
T/F 0.553 ambiguous 0.5737 pathogenic -1.048 Destabilizing 1.0 D 0.875 deleterious None None None None I
T/G 0.412 ambiguous 0.428 ambiguous -0.91 Destabilizing 1.0 D 0.798 deleterious None None None None I
T/H 0.467 ambiguous 0.4849 ambiguous -1.285 Destabilizing 1.0 D 0.812 deleterious None None None None I
T/I 0.4151 ambiguous 0.4078 ambiguous -0.32 Destabilizing 1.0 D 0.86 deleterious N 0.504053641 None None I
T/K 0.4256 ambiguous 0.4794 ambiguous -0.714 Destabilizing 1.0 D 0.866 deleterious None None None None I
T/L 0.2041 likely_benign 0.1995 benign -0.32 Destabilizing 0.999 D 0.765 deleterious None None None None I
T/M 0.1656 likely_benign 0.1693 benign 0.127 Stabilizing 1.0 D 0.775 deleterious None None None None I
T/N 0.2816 likely_benign 0.2746 benign -0.591 Destabilizing 1.0 D 0.805 deleterious N 0.482906582 None None I
T/P 0.8225 likely_pathogenic 0.8169 pathogenic -0.424 Destabilizing 1.0 D 0.849 deleterious N 0.50688664 None None I
T/Q 0.3878 ambiguous 0.4069 ambiguous -0.888 Destabilizing 1.0 D 0.858 deleterious None None None None I
T/R 0.3756 ambiguous 0.4365 ambiguous -0.374 Destabilizing 1.0 D 0.852 deleterious None None None None I
T/S 0.1662 likely_benign 0.1759 benign -0.802 Destabilizing 0.999 D 0.578 neutral N 0.470959788 None None I
T/V 0.3088 likely_benign 0.299 benign -0.424 Destabilizing 0.999 D 0.666 neutral None None None None I
T/W 0.8422 likely_pathogenic 0.8558 pathogenic -0.974 Destabilizing 1.0 D 0.817 deleterious None None None None I
T/Y 0.6106 likely_pathogenic 0.6317 pathogenic -0.733 Destabilizing 1.0 D 0.864 deleterious None None None None I

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.